Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2

被引:45
作者
Liu, Qiuli [1 ]
Pang, Jian [1 ]
Wang, Lin-ang [1 ]
Huang, Zhuowei [1 ]
Xu, Jing [1 ]
Yang, Xingxia [1 ]
Xie, Qiubo [1 ]
Huang, Yiqiang [1 ]
Tang, Tang [1 ]
Tong, Dali [1 ]
Liu, Gaolei [1 ]
Wang, Luofu [1 ]
Zhang, Dianzheng [2 ]
Ma, Qiang [3 ]
Xiao, Hualiang [3 ]
Lan, Weihua [1 ]
Qin, Jun [1 ,4 ]
Jiang, Jun [1 ]
机构
[1] Army Med Univ, Daping Hosp, Inst Surg Res, Dept Urol, 10 Changliang Zhilu, Chongqing 400042, Peoples R China
[2] Philadelphia Coll Osteopath Med, Dept Bio Med Sci, Philadelphia, PA USA
[3] Army Med Univ, Daping Hosp, Inst Surg Res, Dept Pathol, Chongqing, Peoples R China
[4] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Nutr & Hlth Sci,CAS Key Lab Tissue, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
prostate cancer; neuroendocrine; PHF8; FOXA2; histone; demethylase; epigenetic; transcriptional factor; TRAMP mice; tissue microarray; ADENOCARCINOMA; EXPRESSION; CELLS; DIFFERENTIATION; CARCINOMA; MODEL;
D O I
10.1002/path.5557
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neuroendocrine prostate cancer (NEPC) is a more aggressive subtype of castration-resistant prostate cancer (CRPC). Although it is well established that PHF8 can enhance prostate cancer cell proliferation, whether PHF8 is involved in prostate cancer initiation and progression is relatively unclear. By comparing the transgenic adenocarcinoma of the mouse prostate (TRAMP) mice with or without Phf8 knockout, we systemically examined the role of PHF8 in prostate cancer development. We found that PHF8 plays a minimum role in initiation and progression of adenocarcinoma. However, PHF8 is essential for NEPC because not only is PHF8 highly expressed in NEPC but also animals without Phf8 failed to develop NEPC. Mechanistically, PHF8 transcriptionally upregulates FOXA2 by demethylating and removing the repressive histone markers on the promoter region of the FOXA2 gene, and the upregulated FOXA2 subsequently regulates the expression of genes involved in NEPC development. Since both PHF8 and FOXA2 are highly expressed in NEPC tissues from patients or patient-derived xenografts, the levels of PHF8 and FOXA2 can either individually or in combination serve as NEPC biomarkers and targeting either PHF8 or FOXA2 could be potential therapeutic strategies for NEPC treatment. (c) 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
引用
收藏
页码:106 / 118
页数:13
相关论文
共 39 条
[1]   Differential expression analysis for sequence count data [J].
Anders, Simon ;
Huber, Wolfgang .
GENOME BIOLOGY, 2010, 11 (10)
[2]   HTSeq-a Python']Python framework to work with high-throughput sequencing data [J].
Anders, Simon ;
Pyl, Paul Theodor ;
Huber, Wolfgang .
BIOINFORMATICS, 2015, 31 (02) :166-169
[3]   Aberrant BAF57 Signaling Facilitates Prometastatic Phenotypes [J].
Balasubramaniam, Sucharitha ;
Comstock, Clay E. S. ;
Ertel, Adam ;
Jeong, Kwang Won ;
Stallcup, Michael R. ;
Addya, Sankar ;
McCue, Peter A. ;
Ostrander, William F., Jr. ;
Augello, Michael A. ;
Knudsen, Karen E. .
CLINICAL CANCER RESEARCH, 2013, 19 (10) :2657-2667
[4]   Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer [J].
Beltran, Himisha ;
Prandi, Davide ;
Mosquera, Juan Miguel ;
Benelli, Matteo ;
Puca, Loredana ;
Cyrta, Joanna ;
Marotz, Clarisse ;
Giannopoulou, Eugenia ;
Chakravarthi, Balabhadrapatruni V. S. K. ;
Varambally, Sooryanarayana ;
Tomlins, Scott A. ;
Nanus, David M. ;
Tagawa, Scott T. ;
Van Allen, Eliezer M. ;
Elemento, Olivier ;
Sboner, Andrea ;
Garraway, Levi A. ;
Rubin, Mark A. ;
Demichelis, Francesca .
NATURE MEDICINE, 2016, 22 (03) :298-305
[5]   Aggressive Variants of Castration-Resistant Prostate Cancer [J].
Beltran, Himisha ;
Tomlins, Scott ;
Aparicio, Ana ;
Arora, Vivek ;
Rickman, David ;
Ayala, Gustavo ;
Huang, Jiaoti ;
True, Lawrence ;
Gleave, Martin E. ;
Soule, Howard ;
Logothetis, Christopher ;
Rubin, Mark A. .
CLINICAL CANCER RESEARCH, 2014, 20 (11) :2846-2850
[6]   Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets [J].
Beltran, Himisha ;
Rickman, David S. ;
Park, Kyung ;
Chae, Sung Suk ;
Sboner, Andrea ;
MacDonald, Theresa Y. ;
Wang, Yuwei ;
Sheikh, Karen L. ;
Terry, Stephane ;
Tagawa, Scott T. ;
Dhir, Rajiv ;
Nelson, Joel B. ;
de la Taille, Alexandre ;
Allory, Yves ;
Gerstein, Mark B. ;
Perner, Sven ;
Pienta, Kenneth J. ;
Chinnaiyan, Arul M. ;
Wang, Yuzhuo ;
Collins, Colin C. ;
Gleave, Martin E. ;
Demichelis, Francesca ;
Nanus, David M. ;
Rubin, Mark A. .
CANCER DISCOVERY, 2011, 1 (06) :487-495
[7]   The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer [J].
Bishop, Jennifer L. ;
Thaper, Daksh ;
Vahid, Sepideh ;
Davies, Alastair ;
Ketola, Kirsi ;
Kuruma, Hidetoshi ;
Jama, Randy ;
Nip, Ka Mun ;
Angeles, Arkhjamil ;
Johnson, Fraser ;
Wyatt, Alexander W. ;
Fazli, Ladan ;
Gleave, Martin E. ;
Lin, Dong ;
Rubin, Mark A. ;
Collins, Colin C. ;
Wang, Yuzhuo ;
Beltran, Himisha ;
Zoubeidi, Amina .
CANCER DISCOVERY, 2017, 7 (01) :54-71
[8]   Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion [J].
Bjorkman, M. ;
Ostling, P. ;
Harma, V. ;
Virtanen, J. ;
Mpindi, J-P ;
Rantala, J. ;
Mirtti, T. ;
Vesterinen, T. ;
Lundin, M. ;
Sankila, A. ;
Rannikko, A. ;
Kaivanto, E. ;
Kohonen, P. ;
Kallioniemi, O. ;
Nees, M. .
ONCOGENE, 2012, 31 (29) :3444-3456
[9]   Phf8 histone demethylase deficiency causes cognitive impairments through the mTOR pathway [J].
Chen, Xuemei ;
Wang, Shuai ;
Zhou, Ying ;
Han, Yanfei ;
Li, Shengtian ;
Xu, Qing ;
Xu, Longyong ;
Zhu, Ziqi ;
Deng, Youming ;
Yu, Lu ;
Song, Lulu ;
Chen, Adele Pin ;
Song, Juan ;
Takahashi, Eiki ;
He, Guang ;
He, Lin ;
Li, Weidong ;
Chen, Charlie Degui .
NATURE COMMUNICATIONS, 2018, 9
[10]   Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer [J].
Chiaverotti, Teresa ;
Couto, Suzana S. ;
Donjacour, Annemarie ;
Mao, Jian-Hua ;
Nagase, Hiroki ;
Cardiff, Robert D. ;
Cunha, Gerald R. ;
Balmain, Allan .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 172 (01) :236-246